Update on Bimervax ® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study (NTC05142553)

Rev Esp Quimioter. 2023 Sep 8:cambra08sep2023. doi: 10.37201/req/085.2023. Online ahead of print.NO ABSTRACTPMID:37675837 | DOI:10.37201/req/085.2023

Source: Revista Espanola de Quimioterapia - September 7, 2023 Category: Drugs & Pharmacology Authors: C Borralleras J Castrodeza Sanz P Arrazola C C ámara Hijón J M Eiros J Castrodeza Sanz P Arrazola C C ámara Hijón M Fern ández-Prada A Gil de Miguel G Mirada Masip F Moraga-Llop D Oca ña Rodríguez J Puig-Barber à J V ázquez J Vergara-Alert S de C Source Type: research